Contract for the transfer of technology
with Samjin Pharmaceutical Co., Ltd.
(Patented medicine Clopidogrel)
2009.09
Established R&D Institute
2012.06
Patented SA-001 oral administrative drug for Xerophthalmia,
Contract for the transfer of technology with Samjin Pharmaceutical Co., Ltd. (SA-001)
Phase II study is on progress.
2019.05
Development of Uvimax DHHB & Uvimax TDSA UV blocking active ingredient
2019.11
Started to Pilot the Uvimax DHHB
2020.02
Started to product the Uvimax DHHB
2021.12
Completed building Janghang Factory (Janghang, Seocheon)